Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Ecsflam 50 mg/325 mg/32.5 mg Tablet

Prescription Icon
Prescription Required

Marketer

Ecstasy Biotech Pvt Ltd

Salt Composition

Diclofenac (50mg) + Paracetamol (325mg) + Dextropropoxyphene (32.5mg)

Overview Ecsflam 50 mg/325 mg/32.5 mg Tablet

Rheumacin 50 mg/325 mg/32.5 mg tablets offer pain relief. This medication targets pain and inflammation associated with conditions such as rheumatoid arthritis, ankylosing spondylitis, and osteoarthritis. It's also indicated for fever reduction and pain management in muscles, back, teeth, ears, and throat. Rheumacin should be ingested with or without food, strictly following your physician's prescribed dosage and duration. Exceeding the recommended dose or treatment period is strongly discouraged. Commonly reported side effects include nausea, vomiting, dyspepsia, abdominal discomfort, and appetite suppression. Persistent or bothersome side effects warrant immediate medical attention. Your doctor can advise on mitigating these effects. Prior to commencing treatment, individuals with pre-existing cardiac, renal, hepatic issues, or stomach ulcers should consult their physician. Complete disclosure of all current medications is essential for safe and effective use. Pregnant or lactating individuals must seek medical advice before taking Rheumacin.

Primary Ingredients of Ecsflam 50 mg/325 mg/32.5 mg Tablet

The provided text is "undefined." Therefore, no rephrasing is possible.

Uses of Ecsflam 50 mg/325 mg/32.5 mg Tablet

Analgesia

Major Benefits of Ecsflam 50 mg/325 mg/32.5 mg Tablet:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Ecsflam 50 mg/325 mg/32.5 mg Tablets can be consumed with or without food, although consistent timing is recommended.

Common Side effects of Ecsflam 50 mg/325 mg/32.5 mg Tablet:

  • Nausea
  • Vomiting
  • Indigestion
  • Stomach pain
  • Loss of appetite
  • Dizziness
  • Sleepiness
  • Heartburn

How to use Ecsflam 50 mg/325 mg/32.5 mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Ecsflam 50 mg/325 mg/32.5 mg Tablets can be administered with or without food, although consistent timing is recommended.

How Ecsflam 50 mg/325 mg/32.5 mg Tablet works:

Ecsflam tablets (50mg/325mg/32.5mg Diclofenac/Paracetamol/Dextropropoxyphene) combine three active ingredients to alleviate pain and reduce fever. Paracetamol acts as an analgesic and antipyretic, while Diclofenac, a non-steroidal anti-inflammatory drug (NSAID), works by inhibiting the production of pain-inducing chemical messengers in the central nervous system. Dextropropoxyphene, a potent opioid analgesic, further diminishes pain perception by interrupting pain signal transmission to the brain.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Ecsflam 50 mg/325 mg/32.5 mg tablets with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Ecsflam 50 mg/325 mg/32.5 mg tablets during pregnancy poses a confirmed risk to the fetus. Prescribing may occur in exceptional, life-threatening circumstances where potential benefits outweigh the known hazards. A physician's consultation is crucial.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Ecsflam 50 mg/325 mg/32.5 mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a risk to the infant. Low doses of this medication may induce drowsiness and neurological effects in nursing infants.

DrivingDrivingUNSAFE

Driving ability may be impaired by Ecsflam 50 mg/325 mg/32.5 mg Tablets, which can induce side effects such as headaches, blurred vision, dizziness, or drowsiness in certain individuals.

KidneyKidneyCAUTION

Patients with kidney impairment should use Ecsflam 50 mg/325 mg/32.5 mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Ecsflam 50 mg/325 mg/32.5 mg tablets are contraindicated in those with terminal kidney disease.

LiverLiverCAUTION

Patients with liver impairment should use Ecsflam 50 mg/325 mg/32.5 mg tablets cautiously. Dosage modification may be necessary; physician consultation is advised.

What if you forget to take Ecsflam 50 mg/325 mg/32.5 mg Tablet :

Should you forget a dose of Ecsflam 50 mg/325 mg/32.5 mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Ecsflam 50 mg/325 mg/32.5 mg Tablet

LabelValue
Developing Habits Affirmative.
Treatment Category Pain Relief Medications
Ecsflam 50 mg/325 mg/32.5...
34
MRP 41
16% off